Skip to content
Trial Eligibility
Menu

Forebrain Electroneutral Transporters in Salt-sensitive Hypertension: an MRI Study

NCT06094816

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Salt-Sensitivity of Blood Pressure

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
40 to 60 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Delaware
Last updated on ClinicalTrials.gov
March 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Delaware · 1

  • University of Delaware · Newark, DE

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.